AU2001267878A1 - Hypoglycemics - Google Patents

Hypoglycemics

Info

Publication number
AU2001267878A1
AU2001267878A1 AU2001267878A AU6787801A AU2001267878A1 AU 2001267878 A1 AU2001267878 A1 AU 2001267878A1 AU 2001267878 A AU2001267878 A AU 2001267878A AU 6787801 A AU6787801 A AU 6787801A AU 2001267878 A1 AU2001267878 A1 AU 2001267878A1
Authority
AU
Australia
Prior art keywords
hypoglycemics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267878A
Inventor
Hiroshi Ikawa
Jiro Inaba
Kazuhiro Kojima
Hideki Kosono
Takashi Nakamura
Masato Nishimura
Keiji Okada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2001267878A1 publication Critical patent/AU2001267878A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AU2001267878A 2000-07-05 2001-06-29 Hypoglycemics Abandoned AU2001267878A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000203993 2000-07-05
JP2000-203993 2000-07-05
JP2000229505 2000-07-28
JP2000-229505 2000-07-28
PCT/JP2001/005625 WO2002002101A1 (en) 2000-07-05 2001-06-29 Hypoglycemics

Publications (1)

Publication Number Publication Date
AU2001267878A1 true AU2001267878A1 (en) 2002-01-14

Family

ID=26595442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267878A Abandoned AU2001267878A1 (en) 2000-07-05 2001-06-29 Hypoglycemics

Country Status (4)

Country Link
US (1) US20030191323A1 (en)
EP (1) EP1300142A4 (en)
AU (1) AU2001267878A1 (en)
WO (1) WO2002002101A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
AU2001267879A1 (en) 2000-07-05 2002-01-14 Ajinomoto Co., Inc. Acylsulfonamide derivatives
CN100344616C (en) * 2001-06-12 2007-10-24 维尔斯达医疗公司 Compounds for the treatment of metabolic disorders
AR037097A1 (en) 2001-10-05 2004-10-20 Novartis Ag ACILSULFONAMID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT
JP2005194191A (en) * 2001-12-28 2005-07-21 Ajinomoto Co Inc Drug against obesity and therapeutic drug for fatty liver
JP2005162612A (en) * 2002-01-09 2005-06-23 Ajinomoto Co Inc Acylsulfonamide derivative
US7615575B2 (en) 2003-02-13 2009-11-10 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
JPWO2005108370A1 (en) * 2004-04-16 2008-03-21 味の素株式会社 Benzene compounds
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US8853392B2 (en) * 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3668215A (en) * 1967-11-25 1972-06-06 Bayer Ag Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups
DE2135805A1 (en) * 1971-07-17 1973-02-08 Boehringer Mannheim Gmbh Blood sugar lowering sulphonyl urea and sulphonyl semicarbocides and the process for their manufacture
BE791638A (en) * 1971-11-20 1973-05-21 Hoechst Ag SULFONYL-UREES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
DE2230543A1 (en) * 1972-06-22 1974-01-17 Hoechst Ag BENZENE SULFONYL URUBE AND METHOD FOR MANUFACTURING IT
DE19621522A1 (en) * 1996-05-29 1997-12-04 Hoechst Schering Agrevo Gmbh New N-acylsulfonamides, new mixtures of herbicides and antidots and their use
JPH11171848A (en) * 1997-09-26 1999-06-29 Fujirebio Inc Aromatic amide derivative
JPH11171856A (en) * 1997-09-26 1999-06-29 Fujirebio Inc Acylsulfonamide derivative

Also Published As

Publication number Publication date
WO2002002101A1 (en) 2002-01-10
EP1300142A1 (en) 2003-04-09
EP1300142A4 (en) 2004-05-19
US20030191323A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001267878A1 (en) Hypoglycemics
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001260192A1 (en) Glycinamides
AU2001284173A1 (en) Calycins
AU2001295713A1 (en) Blast-processing
AU2001262711A1 (en) Cytoprotectors